NL
Nuveen LLC Portfolio holdings
AUM
$362B
This Quarter Return
-3.57%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$330B
AUM Growth
–
Cap. Flow
+$329B
Cap. Flow
% of AUM
99.82%
Top 10 Holdings %
Top 10 Hldgs %
28%
Holding
3,279
New
3,246
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Microsoft
MSFT
|
$18.7B |
| 2 |
Apple
AAPL
|
$17.5B |
| 3 |
NVIDIA
NVDA
|
$15.1B |
| 4 |
Amazon
AMZN
|
$11.7B |
| 5 |
Broadcom
AVGO
|
$6.65B |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 28.46% |
| 2 | Financials | 13.55% |
| 3 | Healthcare | 11.18% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
3176
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $101K | ﹤0.01% |
+1,144
| New | +$101K |
|
|
RDNW
3177
RideNow Group, Inc. Class B Common Stock
RDNW
$138M
| $98.5K | ﹤0.01% |
+34,914
| New | +$98.5K |
|
|
CLPR
3178
Clipper Realty
CLPR
$67.8M
| $98.3K | ﹤0.01% |
+25,586
| New | +$98.3K |
|
3179
BlackRock MuniHoldings Fund
MHD
$582M
| $98.1K | ﹤0.01% |
+10,127
| New | +$98.1K |
|
3180
Tevogen Bio Holdings
TVGN
$175M
| $97.5K | ﹤0.01% |
+90,253
| New | +$97.5K |
|
3181
TScan Therapeutics
TCRX
$106M
| $96.5K | ﹤0.01% |
+69,962
| New | +$96.5K |
|
3182
Paysign
PAYS
$288M
| $95.4K | ﹤0.01% |
+45,010
| New | +$95.4K |
|
3183
QuickLogic
QUIK
$80.7M
| $94.9K | ﹤0.01% |
+18,565
| New | +$94.9K |
|
3184
VirTra
VTSI
$65.8M
| $93.8K | ﹤0.01% |
+23,041
| New | +$93.8K |
|
|
CTNM
3185
Contineum Therapeutics
CTNM
$297M
| $92.9K | ﹤0.01% |
+13,307
| New | +$92.9K |
|
3186
Q32 Bio
QTTB
$20.9M
| $92.2K | ﹤0.01% |
+55,886
| New | +$92.2K |
|
|
KG
3187
Kestrel Group, Ltd.
KG
$198M
| $92K | ﹤0.01% |
+8,070
| New | +$92K |
|
3188
Kyverna Therapeutics
KYTX
$161M
| $91.7K | ﹤0.01% |
+47,508
| New | +$91.7K |
|
3189
Veru
VERU
$48.5M
| $87.5K | ﹤0.01% |
+17,856
| New | +$87.5K |
|
3190
Fractyl Health
GUTS
$66.2M
| $86.8K | ﹤0.01% |
+72,958
| New | +$86.8K |
|
3191
Acumen Pharmaceuticals
ABOS
$82.4M
| $86.3K | ﹤0.01% |
+78,446
| New | +$86.3K |
|
3192
Metagenomi
MGX
$67.2M
| $86K | ﹤0.01% |
+63,248
| New | +$86K |
|
3193
Rekor Systems
REKR
$139M
| $85.3K | ﹤0.01% |
+96,176
| New | +$85.3K |
|
3194
Renovaro
RENB
$51.4M
| $82.4K | ﹤0.01% |
+151,681
| New | +$82.4K |
|
3195
Lifetime Brands
LCUT
$92.9M
| $82.1K | ﹤0.01% |
+16,644
| New | +$82.1K |
|
3196
Telomir Pharmaceuticals
TELO
$38.1M
| $80.7K | ﹤0.01% |
+24,990
| New | +$80.7K |
|
3197
XBiotech
XBIT
$90.9M
| $80.6K | ﹤0.01% |
+24,879
| New | +$80.6K |
|
3198
Mersana Therapeutics
MRSN
$34.8M
| $79.9K | ﹤0.01% |
+9,289
| New | +$79.9K |
|
3199
Harvard Bioscience
HBIO
$21.1M
| $79.2K | ﹤0.01% |
+139,999
| New | +$79.2K |
|
3200
Ramaco Resources Class B
METCB
$1.05B
| $78.9K | ﹤0.01% |
+11,102
| New | +$78.9K |
|